术前预后营养指数评估肝细胞癌患者肝切除术后早期肿瘤复发价值探讨*

doi:10.3969/j.issn.1672-5069.2019.04.028

实用肝脏病杂志 ›› 2019, Vol. 22 ›› Issue (4): 561-564.doi: 10.3969/j.issn.1672-5069.2019.04.028

术前预后营养指数评估肝细胞癌患者肝切除术后早期肿瘤复发价值探讨^*

戴青云, 王润东, 荚卫东

230001合肥市安徽医科大学附属省立医院普外科

收稿日期:2019-01-16 出版日期:2019-07-10 发布日期:2019-07-19
通讯作者: 荚卫东,E-mail:jwd2013@126.com
作者简介:戴青云,男,25岁,硕士研究生。主要从事肝脏外科临床研究。E-mail:578010239@qq.com
基金资助:
*2017年度安徽省重点研究与开发项目（编号：1704a0802150）

Prediction of early tumor recurrence by predictive nutritional index in patients with hepatocellular carcinoma undergoing hepatectomy

Dai Qingyun, Wang Rundong, Jia Weidong

Department of Liver Surgery,Provincial Hospital Affiliated to Anhui Medical University,Hefei 230001,Anhui Province,China

Received:2019-01-16 Online:2019-07-10 Published:2019-07-19

摘要/Abstract

摘要： 目的探讨术前预后营养指数（PNI）和中性粒细胞/淋巴细胞比值（NLR）评估肝细胞癌（HCC）患者在肿瘤切除术后早期肿瘤复发的价值。方法 2012年1月~2015年12月诊治的HCC患者237例,均接受肝癌切除术。根据术前检查结果计算 PNI 和NLR,绘制受试者工作特征(ROC)曲线,由最高约登指数确定截断点,比较不同PNI和NLR组患者临床和病理学特征。应用单因素和多因素 Logistic 回归分析影响HCC术后早期肿瘤复发的因素。结果本组高PNI组（≥45.95）128例,低PNI组（<45.95）109例,高NLR组（≥2.52）99例,低NLR组（<2.52）138例;高PNI组术后早期肿瘤复发率为51.6%（66/128）,显著低于低PNI组的73.4%（80/109,P<0.01）,低NLR组早期肿瘤复发率为55.8%（77/138）,显著低于高NLR组的69.7%（69/99,P<0.05）;经单因素和多因素 Logistic 回归分析发现高PNI（HR=2.036,95%CI=1.113~3.722,P=0.021）、低NLR（HR=2.235,95%CI=1.221~4.091,P=0.009）和TNM分期晚（HR=2.540,95%CI=1.237~5.215,P=0.011）是肝癌根治术后早期肿瘤复发的独立危险因素。结论高PNI和低NLR对预测HCC患者术后早期肿瘤复发具有潜在的应用价值。

关键词: 肝细胞癌, 肝癌切除术, 预后营养指数, 中性粒细胞/淋巴细胞比值, 早期肿瘤复发

Abstract: Objective The aim of this study was to investigate the prediction of early tumor recurrence by predictive nutritional index （PNI） and neutrophil/lymphocyte ratio （NLR） in patients with hepatocellular carcinoma （HCC） undergoing hepatectomy.Methods The clinical data of 237 patients with HCC were recruited in Anhui Provincial Hospital between January 2012 and December 2015,and all patients underwent partial hepatectomy. The PNI and NLR receiver operating characteristic curves（ROC） were plotted. Multivariate Logistic analysis was applied to predict the risk factors for postoperative early tumor recurrence.Results There were 128 patients with high （≥45.95） and 109 patients with low PNI score （<45.95）,and 99 patients with high （≥2.52） and 138 patients with low NLR score（<2.52）;the early tumor recurrence rate in patients with high PNI score was 51.6% （66/128）,much lower than 73.4% （80/109） in those with low PNI score（P<0.01）,and the early tumor recurrence rate in patients with low NLR score was 55.8% （77/138）,significantly lower than 69.7% （69/99） in those with high NLR score（P<0.05）;Univariate and multivariate Logistic regression analysis showed high PNI score（HR=2.036） 95% CI=1.113-3.722,P=0.021）,low NLR score（HR=2.235,95% CI=1.221-4.091,P=0.009） and advanced TNM staging（HR=2.540,95% CI=1.237-5.215,P=0.011） were the independent risk factors for early tumor recurrence after radical resection of liver cancer. Conclusion The calculation of PNI and NLR pre-operationally might help predict the early tumor recurrence after hepatectomy in patients with HCC.

Key words: Hepatoma, Hepatectomy, Predictive nutritional index, Neutrophil/lymphocyte ratio, Early tumor recurrence

戴青云, 王润东, 荚卫东. 术前预后营养指数评估肝细胞癌患者肝切除术后早期肿瘤复发价值探讨^*[J]. 实用肝脏病杂志, 2019, 22(4): 561-564.

Dai Qingyun, Wang Rundong, Jia Weidong. Prediction of early tumor recurrence by predictive nutritional index in patients with hepatocellular carcinoma undergoing hepatectomy[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 561-564.

参考文献

[1] Liu C,Li L,Lu W,et al.Neutrophil-lymphocyte ratio plus prognostic nutritional index predicts the outcomes of patients with unresectable hepatocellular carcinoma after transarterial chemoembolization. Sci Rep UK,2017,7(1):13873.
[2] Chun J M,Kwon H J,Sohn J,et al.Prognostic factors after early recurrence in patients who underwent curative resection for hepato-cellular carcinoma. J Surg Oncol,2011,103(2):148-151.
[3] Mano Y,Shirabe K,Yamashita Y,et al.Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma:a retrospective analysis. An Surg,2013,258(2):301-305.
[4] Yamamura K,Sugimoto H,Kanda M,et al.Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection. J Hepatobiliary Pancreat Sci,2015,21(9):682-688.
[5] 中国抗癌协会肝癌专业委员会. 原发性肝癌规范化病理诊断指南(2015年版). 中华肝胆外科杂志,2015,21(3):865-872.
[6] Takayama T.Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma:a randomised trial. Lancet,2000,356(9232):802-807.
[7] Yang Z,Zhang B,Hou L,et al.Pre-operative prognostic nutritional index predicts the outcomes for triple-negative breast cancer. Tumour Biol,2014,35(12):12165-12171.
[8] Van C E,Arends J.The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs,2005,9(2):S51-S63.
[9] Schütte K,Tippelt B,Schulz C,et al.Malnutrition is a prognostic factor in patients with hepatocellular carcinoma (HCC). Clin Nutr,2015,34(6):1122-1127.
[10] 王文清,叶超平,刘逢生,等. 胃癌术后复发的临床分析. 中华普通外科杂志,2010,26(2):39-40.
[11] Oh CA,Kim DH,Oh SJ,et al.Nutritional risk index as a predictor of postoperative wound complications after gastrectomy. World J Gastroenterol,2012,18(7):673-678.
[12] Lomivorotov V,Efremov S,Boboshko V.Low preoperative total lymphocyte count as a predictor of poor outcome in adult cardiac surgery. Critical Care,2011,15(Suppl 1):32-34.
[13] Mazaki T,Ishii Y,Murai I.Immunoenhancing enteral and parenteral nutrition for gastrointestinal surgery:A multiple-treatments Meta-analysis. Ann Surg,2015,36:261.
[14] Jiang N,Deng J Y,Liu Y,et al.The role of preoperative neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after radical resection for gastric cancer. Biomarkers,2014,19(6):444-451.
[15] Mohri Y,Inoue Y,Tanaka K,et al.Prognostic nutritional index predicts postoperative outcome in colorectal cancer. World J Surg,2013,37(11):2688-2692.
[16] 徐小元,丁惠国,李文刚,等. 肝硬化腹水及相关并发症的诊疗指南. 实用肝脏病杂志,2018,21(1):21-31.
[17] Jablonska J,Leschner S,Westphal K,et al.Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. J Clin Invest,2010,120(4):1151-1164.
[18] Young AL,Malik HZ,Abu-Hilal M,et al.Large hepatocellular carcinoma:time to stop preoperative biopsy. J Am Coll Surg,2007,205(3):453-462.
[19] 黄建文,杨友超,徐长青,等. 根治性切除治疗原发性肝癌患者预后分析. 实用肝脏病杂志,2018,21(4):521-524.

术前预后营养指数评估肝细胞癌患者肝切除术后早期肿瘤复发价值探讨^*

Prediction of early tumor recurrence by predictive nutritional index in patients with hepatocellular carcinoma undergoing hepatectomy

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	曹策, 郁义星, 王贝贝, 赵卫峰. 增强磁共振成像联合血清甲胎蛋白和脱-γ-羧基凝血酶原诊断肝细胞癌临床价值探讨[J]. 实用肝脏病杂志, 2019, 22(6): 896-899.
[2]	朱俊, 丁莹, 王世清, 张野, 刘野, 刘泽刚. 围手术期应用乌司他丁治疗对肝细胞癌患者肝切除术后外周血Th22细胞百分比和血浆白细胞介素-22的影响*[J]. 实用肝脏病杂志, 2019, 22(5): 720-723.
[3]	王刚, 赵洪波, 朱亚玲, 蒋保三, 张越美, 刁勇. 基于数据库分析肝细胞癌细胞XPO5基因水平变化及其临床意义*[J]. 实用肝脏病杂志, 2019, 22(5): 724-727.
[4]	杨富存, 尚怀学, 盖永浩. 钆塞酸二钠增强磁共振扫描诊断肝脏局灶性病变研究^*[J]. 实用肝脏病杂志, 2019, 22(4): 577-580.
[5]	彭新健, 肖玉辉, 许斯鼎, 石荣跃, 王耀政, 王瑜琳. 放射性肝损伤患者肝脏磁共振扩散加权成像表现特征分析[J]. 实用肝脏病杂志, 2019, 22(3): 373-376.
[6]	乔志忠. 超声造影定量分析鉴别肝脏局灶性结节性增生与原发性肝癌初步探讨[J]. 实用肝脏病杂志, 2019, 22(3): 421-424.
[7]	朱光曦（综述）, 文良志, 陈东风（审校）. 非酒精性脂肪性肝病相关肝细胞癌发病机制研究进展[J]. 实用肝脏病杂志, 2019, 22(3): 453-456.
[8]	王虎明,樊东升,徐杰,刘险峰,周宁,丽敏,包娜娜. 肝细胞癌患者癌组织miRNA-30c水平变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2019, 22(2): 248-251.
[9]	幸奠奎,程婧. ¹⁸F-FDG PET/CT检查指标预测肝细胞癌微血管侵犯临床价值研究^*[J]. 实用肝脏病杂志, 2019, 22(2): 252-254.
[10]	王秀清,马艳君,詹晋莉. 肝动脉化疗栓塞术联合超声引导下微波消融术治疗特殊部位原发性肝癌患者疗效及安全性分析 ^*[J]. 实用肝脏病杂志, 2019, 22(2): 260-263.
[11]	张帮健,魏寿存,杨小燕. 右美托咪啶联合丙泊酚麻醉对肝癌切除术患者围手术期血清细胞因子和术后苏醒质量的影响 ^*[J]. 实用肝脏病杂志, 2019, 22(2): 264-267.
[12]	张小舟,帅领,王庆大,杨楠. 接受TACE治疗的肝细胞癌患者血清miR-335水平变化及其对预后判断的价值分析^*[J]. 实用肝脏病杂志, 2019, 22(2): 268-271.
[13]	王朝霞,关珂,付三仙,王慧杰. 肠内肠外联合营养支持治疗肝细胞癌患者围术期临床研究^*[J]. 实用肝脏病杂志, 2019, 22(2): 272-275.
[14]	赵西太综述,聂青和审校. 循环microRNA早期诊断肝细胞癌研究现状及方法学探讨[J]. 实用肝脏病杂志, 2019, 22(2): 297-300.
[15]	范建高. 2018年《实用肝脏病杂志》精彩回顾[J]. 实用肝脏病杂志, 2019, 22(1): 1-3.